These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3976024)

  • 21. [Rosette test in Hodgkin's disease. Relation to the presence of antilymphocyte antibodies].
    Manconi PE; Del Giacco GS; Tognella S; Mantovani G; Turno R; Grifoni V
    Boll Ist Sieroter Milan; 1974; 53(4):565-8. PubMed ID: 4615726
    [No Abstract]   [Full Text] [Related]  

  • 22. [T- and B-cell nature of blood lymphocytes in Hodgkin's disease].
    Cohnen G; König E; Augener W; Douglas SD; Brittinger G
    Verh Dtsch Ges Inn Med; 1973; 79():492-4. PubMed ID: 4545357
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hodgkin's disease].
    Bousser J
    Ann Med Interne (Paris); 1970 Mar; 121(3):265-7. PubMed ID: 5507500
    [No Abstract]   [Full Text] [Related]  

  • 24. Implications of persistent T cell abnormalities for the etiology of Hodgkin's disease.
    Fisher RI
    Cancer Treat Rep; 1982 Apr; 66(4):681-7. PubMed ID: 6210434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delayed cutaneous hypersensitivity and blood lymphocyte count in advanced Hodgkin's and non-Hodgkin's lymphomas.
    Gupta S; Seth SK; Udupa KN; Sen PC; Rastogi BL
    Ann Chir Gynaecol; 1980; 69(2):79-83. PubMed ID: 7377739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell-mediated immunity, serum and lymphocyte zinc levels in Hodgkin's disease.
    Acar S; Ersey F; Sanal O; Bechel I; Gebri N
    Prog Clin Biol Res; 1983; 129():255-60. PubMed ID: 6657707
    [No Abstract]   [Full Text] [Related]  

  • 27. Lupus vulgaris and Hodgkin's disease.
    Schein PS; Vickers HR
    Arch Dermatol; 1972 Feb; 105(2):244-6. PubMed ID: 5060868
    [No Abstract]   [Full Text] [Related]  

  • 28. [Immunologic changes in patients with Hodgkin's disease in clinical remission and recurrence].
    Ares BR; Sasiain MD; Brezavscek DM; Fejes M; Bachmann AE
    Medicina (B Aires); 1981; 41(3):287-92. PubMed ID: 6275237
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunodeficiencies in Hodgkin's disease. Part I: T cell-mediated immunity.
    Gupta S
    Clin Bull; 1981; 11(2):58-65. PubMed ID: 6459892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The target cell for antilymphocyte antibodies in Hodgkin's disease].
    Del Giacco GS; Manconi PE; Tognella S; Mantovani G; Turno R; Grifoni V
    Boll Ist Sieroter Milan; 1974; 53(4):562-4. PubMed ID: 4615725
    [No Abstract]   [Full Text] [Related]  

  • 31. [Paraneoplastic subacute demyelinating neuropathy and Hodgkin's disease. Description of a case with immunological study].
    Graus Ribas F; Cabré Roura M; Gómez Alonso J; Peres Serra J
    Rev Clin Esp; 1981 Sep; 162(6):305-6. PubMed ID: 7330328
    [No Abstract]   [Full Text] [Related]  

  • 32. In vitro leukocyte interferon production in patients with Hodgkin's disease.
    Rassiga-Pidot AL; McIntyre OR
    Cancer Res; 1974 Nov; 34(11):2995-3002. PubMed ID: 4421578
    [No Abstract]   [Full Text] [Related]  

  • 33. Invited discussion: relationship of titers of Epstein-Barr virus to cell-mediated immunity in patients with Hodgkin's disease.
    Levine PH; Reisher JI
    Natl Cancer Inst Monogr; 1973 May; 36():85-7. PubMed ID: 4355354
    [No Abstract]   [Full Text] [Related]  

  • 34. Blastogenic transformation of lymphocytes following phytohaemagglutinin treatment in vitro in malignant lymphomas. I. Hodgkin's disease. (Correlation with immunity response of the cellular type and with the clinical status).
    Libánský J; Lukásová M; Pinosová I
    Neoplasma; 1973; 20(1):51-60. PubMed ID: 4702205
    [No Abstract]   [Full Text] [Related]  

  • 35. [Tuberculosis in the course of Hodgkin's disease].
    Leménager J; Tanguy A; Bérnard Y
    Cah Med; 1972 Apr; 13(5):357-62. PubMed ID: 5055112
    [No Abstract]   [Full Text] [Related]  

  • 36. Distinguishing features of the immunology of Hodgkin's disease in children.
    Tan CT; De Sousa M; Good RA
    Cancer Treat Rep; 1982 Apr; 66(4):969-75. PubMed ID: 7074657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunity in Hodgkin's disease.
    Gutensohn N; Cole P
    Ann Intern Med; 1979 Aug; 91(2):316-7. PubMed ID: 464479
    [No Abstract]   [Full Text] [Related]  

  • 38. [Curableness of Hodgkin's disease].
    Glińska H
    Folia Med Cracov; 1971; 13(4):445-500. PubMed ID: 5139805
    [No Abstract]   [Full Text] [Related]  

  • 39. Hodgkin's disease, mixed cellularity type, with a B-cell immunophenotype. Report of a case and literature review.
    Siebert JD; McClure SP; Banks PM; Gulley ML
    Arch Pathol Lab Med; 1995 May; 119(5):474-9. PubMed ID: 7538289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro evidence of normal lymphocyte function in some patients with Hodgkin's disease and negative delayed cutaneous hypersensitivity.
    Churchill WH; Rocklin RR; Moloney WC; David JR
    Natl Cancer Inst Monogr; 1973 May; 36():99-106. PubMed ID: 4583000
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.